[ad_1]
Gannett Co. Inc.’s stock rose 2.9% early Thursday, after the USA Today publisher beat second-quarter profit estimates by a wide margin, offsetting a revenue miss.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...